The Client is a UK based specialty pharmaceutical company that had acquired global license for a novel biologic, an interleukin 6 antagonist for treatment of multicentric Castleman’s disease from a large pharma company. Client did not have a local presence in Argentina and was seeking a trusted partner to initiate license transfer in Argentina and act as its legal representative in Argentina.
GRP team in Argentina has a decade of experience in obtaining successful approval for new biologics, transferring existing marketing authorization license between companies and managing life cycle of biologics in Argentina according to local regulations. GRP team provided the following services to the clients:
Click the “Learn more” button to access the full case study.